Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology. Postmenopausal osteoporosis (PMOP), which increases the risk of fracture, is the most common bone disease in women. PMOP not only increases the risk of death but also impos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Liang, Jiamin, Wang, Ziyi, Su, Yuangang, Zhan, Yunfei, Wu, Zuoxing, Li, Jing, Li, Xuedong, Chen, Runfeng, Zhao, Jinmin, Xu, Jiake, Liu, Qian, Zhou, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237092/
https://www.ncbi.nlm.nih.gov/pubmed/34194327
http://dx.doi.org/10.3389/fphar.2021.664697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237092/
https://www.ncbi.nlm.nih.gov/pubmed/34194327
http://dx.doi.org/10.3389/fphar.2021.664697

Ejemplares similares